TY - JOUR
T1 - Cohort Profile
T2 - The Ganka-Ekigaku Network (GEN), a Network of Japanese Ophthalmological Epidemiology Studies
AU - for the Ganka-Ekigaku Network (GEN)
AU - Sasaki, Mariko
AU - Miyake, Masahiro
AU - Fujiwara, Kohta
AU - Nanba, Hiroyuki
AU - Akiyama, Masato
AU - Yanagi, Yasuo
AU - Harada, Sei
AU - Tabara, Yasuharu
AU - Yasuda, Miho
AU - Yamashita, Hidetoshi
AU - Kayama, Takamasa
AU - Tsubota, Kazuo
AU - Matsuda, Fumihiko
AU - Hashimoto, Sawako
AU - Ueda, Emi
AU - Ninomiya, Toshiharu
AU - Takebayashi, Toru
AU - Tsujikawa, Akitaka
AU - Sonoda, Koh Hei
AU - Kawasaki, Ryo
N1 - Funding Information:
The Nagahama study was supported by the Nagahama City Office and the non-profit organization Zeroji Club.
Publisher Copyright:
© 2020 Taylor & Francis Group, LLC.
PY - 2021
Y1 - 2021
N2 - Purpose: Japan has been known as a super-aged society, and ageing is a well-known risk factor for blinding eye diseases. However, epidemiological studies in ophthalmology are still scarce in Japan, and the sizes of the cohorts are relatively small. “Ganka-Ekigaku Network” (GEN, an acronym for the epidemiological network in ophthalmology in Japanese) is established to develop a capacity to boost each epidemiological study and enrich a potential inter-study collaboration to identify risk factors of visual impairment in aged society. Methods: We reviewed cohort studies in Japan with the inclusion criteria as: (1) at least n = 1000 at baseline, (2) multiple modalities of ophthalmic data, and (3) diagnosis reviewed by ophthalmologist(s), and (4) ophthalmologists are involved in the investigators group. As of January 2020, GEN includes 4 individual Japanese epidemiological studies namely, Hisayama study, Yamagata Study (Funagata), Tsuruoka Metabolomics Cohort study, and the Nagahama Prospective Genome Cohort for Comprehensive Human Bioscience. Results: GEN includes approximately 25,000 Japanese participants. The baseline surveys started from 1998 to 2012, and since then the data has been prospectively collected approximately every 5 years. A variety of ophthalmic measurements and other factors have been collected in each study in GEN: ophthalmic measurements (fundus photography, optical coherence tomography, etc.), systemic conditions (laboratory data, etc.), and others (DNA, etc.). Conclusion: GEN is an open platform for observational ophthalmic epidemiological studies to share standardized methodologies. While each study in GEN pursues specific and original research questions, standardization of the methods will enable us to conduct reliable meta-analysis/pooled data analyses.
AB - Purpose: Japan has been known as a super-aged society, and ageing is a well-known risk factor for blinding eye diseases. However, epidemiological studies in ophthalmology are still scarce in Japan, and the sizes of the cohorts are relatively small. “Ganka-Ekigaku Network” (GEN, an acronym for the epidemiological network in ophthalmology in Japanese) is established to develop a capacity to boost each epidemiological study and enrich a potential inter-study collaboration to identify risk factors of visual impairment in aged society. Methods: We reviewed cohort studies in Japan with the inclusion criteria as: (1) at least n = 1000 at baseline, (2) multiple modalities of ophthalmic data, and (3) diagnosis reviewed by ophthalmologist(s), and (4) ophthalmologists are involved in the investigators group. As of January 2020, GEN includes 4 individual Japanese epidemiological studies namely, Hisayama study, Yamagata Study (Funagata), Tsuruoka Metabolomics Cohort study, and the Nagahama Prospective Genome Cohort for Comprehensive Human Bioscience. Results: GEN includes approximately 25,000 Japanese participants. The baseline surveys started from 1998 to 2012, and since then the data has been prospectively collected approximately every 5 years. A variety of ophthalmic measurements and other factors have been collected in each study in GEN: ophthalmic measurements (fundus photography, optical coherence tomography, etc.), systemic conditions (laboratory data, etc.), and others (DNA, etc.). Conclusion: GEN is an open platform for observational ophthalmic epidemiological studies to share standardized methodologies. While each study in GEN pursues specific and original research questions, standardization of the methods will enable us to conduct reliable meta-analysis/pooled data analyses.
UR - http://www.scopus.com/inward/record.url?scp=85090977508&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090977508&partnerID=8YFLogxK
U2 - 10.1080/09286586.2020.1815803
DO - 10.1080/09286586.2020.1815803
M3 - Article
C2 - 32924732
AN - SCOPUS:85090977508
SN - 0928-6586
VL - 28
SP - 237
EP - 243
JO - Ophthalmic Epidemiology
JF - Ophthalmic Epidemiology
IS - 3
ER -